|
Monday, October 4, 2004
|
| 08:00 - 09:00 |
Meet the Expert
I |
|
| Meeting 1: |
MALIGNANT OVARIAN GERM CELL TUMOURS
Chairpersons:
D. Gershenson, Houston TX, USA
C-H. Lai, Taoyuan, Taiwan-R.O.C |
Hall D |
| 08:00 |
OPENING REMARKS
D. Gershenson, Houston TX, USA |
|
| 08:05 |
PRINCIPLES OF INITIAL WORK-UP AND PRIMARY
TREATMENT FOR MALIGNANT OVARIAN GERM CELL TUMOURS
P. Schwartz, New Haven CT, USA |
|
| 08:20 |
MANAGEMENT OF PERSISTENT/RECURRENT MALIGNANT
OVARIAN GERM CELL TUMOURS
C-H. Lai, Taipei, Taiwan |
|
| 08:35 |
FERTILITY PRESERVING TREATMENT IN MALIGNANT
OVARIAN GERM CELL TUMOURS
D. Gershenson, Houston, TX, USA |
|
| 08:50 |
Discussion |
|
| 09:00 |
CONCLUSION
C-H. Lai, Taipei, Taiwan |
|
| Meeting 2: |
INTENSITY MODULATED RADIOTHERAPY IN GYNAECOLOGICAL
CANCER
Chairperson:
M.E. Randall, Indianapolis IN, USA |
Hall F |
| 08:00 |
ADVANTAGES IN THE USE OF IMRT IN THE
TREATMENT OF GYNECOLOGIC CANCERS
A. Jhingran, Houston TX, USA |
|
| 08:25 |
PITFALLS IN THE USE OF IMRT FOR GYNECOLOGIC
CANCERS
M.E. Randall, Indianapolis IN, USA |
|
| 08:50 |
Q&A |
|
| Meeting 3: |
OVARIAN CANCER CONCENSUS CONFERENCE
Chairperson:
A. du Bois, Wiesbaden, Germany |
Hall G |
| 08:00 |
SCOPES AND METHODOLOGY
A. du Bois, Wiesbaden, Germany |
| 08:10 |
REPORT FROM WORKING GROUP A: STANDARD
THERAPY - STANDARD REQUIREMENTS
J.T. Thigpen, Jackson MS, USA |
| 08:20 |
REPORT FROM WORKING GROUP B: STUDY METHODOLOGY
- NEW ENDPOINTS
J.B. Vermorken, Edegem, Belgium |
| 08:30 |
REPORT FROM WORKING GROUP C: NEW TREATMENT
OPTIONS - NEW APPROACHES
M.A. Quinn, Melbourne VIC, Australia |
| 08:40 |
CONSENSUS STATEMENT 2004: 12 QUESTIONS
- 12 ANSWERS
A. du Bois, Wiesbaden, Germany |
| Meeting 4: |
COCHRANE REVIEWS
Chairpersons:
J.A. Green, Liverpool, UK
A. Jakobsen, Vejle, Denmark |
Hall E |
| 08:00 |
INTRODUCTION
A.K. Jakobsen, Vejle, Denmark |
| 08:05 |
COCHRANE REVIES, OPPORTUNITIES AND CHALLENGES
IN GYNAECOLOGICAL CANCER
J.A. Green, Liverpool, UK |
| 08:30 |
PRODUCING COCHRANE REVIEWS; WHY DO WE
DO IT?
A. Ansink, Rotterdam, The Netherlands |
| 08:45 |
Discussion |
| Meeting 5: |
RADICAL TRACHELECTOMY
Chairpersons:
K. Reynolds, London, UK
M.L. Roy, Quebec City, QC, Canada |
Hall H |
| 08:00 |
TECHNIQUE OF RADICAL VAGINAL TRACHELECTOMY
M.L. Roy, Quebec City QC, Canada |
| 08:15 |
ONCOLOGIC RESULTS
M.L. Roy, Quebec City QC, Canada |
| 08:30 |
REPRODUCTIVE RESULTS
D. Dargent, Lyon, France |
| 08:45 |
CHEMO-CONIZATION: A MORE CONSERVATIVE
APPROACH
A. Maneo, Monza, Italy |
| Meeting 6: |
OVARIAN CANCER SCREENING TRIALS
Chairpersons:
U. Menon, London, UK
S. Skates, Boston MA, USA |
Hall I |
| 08:00 |
OVERVIEW
S. Skates, Boston, MA, USA |
| 08:10 |
NCI PROSTATE, LUNG, COLORECTAL, AND OVARIAN
CANCER SCREENING TRIAL: INITIAL RESULTS FROM THE OVARIAN
COMPONENT
E. Partridge, Birmingham, AL, USA |
| 08:30 |
UNITED KINGDOM COLLABORATIVE TRIAL OF
OVARIAN CANCER SCREENING
U. Menon, London, UK |
| 08:45 |
SCREENING WOMEN AT HIGH RISK FOR OVARIAN
CANCER: US AND UK HIGH RISK TRIALS
S. Skates, Boston, MA, USA |
| 09:00-10:30 |
State of the
Art Session I |
|
| |
Plenary Session
OVARIAN CANCER
Chairperson:
M.E. Gore, London, UK |
Hall A |
| 09:00 |
RISK ASSESSMENT AND INHERITED PREDISPOSITION
J. Mackay, Cambridge, UK |
|
| 09:15 |
SOMATIC GENETICS IN OVARIAN CARCINOGENESIS
H. Gabra, London, UK |
| 09:30 |
THE NATIONAL OVARIAN CANCER EARLY DETECTION
PROGRAM
D.A. Fishman, Chicago IL, USA |
|
| 09:45 |
THE CURRENT STATUS OF SURGERY FOR OVARIAN
CANCER
J. Dauplat,Clermont-Ferrand, France |
|
| 10:00 |
MANAGEMENT OF EARLY OVARIAN CANCER
B. Trimbos, Leiden, The Netherlands |
|
| 10:15 |
PROGNOSTIC PREDICTORS FOR RESPONSE AND
OUTCOME
M. Dietel, Berlin, Germany |
|
| 11:00 - 12:30 |
Free Communications
Session |
Hall A |
| |
Plenary Session |
|
Chairpersons:
M.L. Friedlander, Friedlander, Australia
A. Ayhan, Ankara, Turkey
|
| 13:30 - 15:00 |
Satellite Symposium
I |
Hall A |
| |
Sponsored by BMS  |
|
| |
LEADING THE WAY TO IMPROVING THE TREATMENT
OF OVARIAN CANCER
Chairperson:
R. Ozols, Philadelphia PA, USA |
| 13:30 |
CHAIRMAN'S INTRODUCTION
R.F. Ozols, Philadelphia PA, USA |
| 13:40 |
PACLITAXEL/PLATINUM: A STANDARD REGIMEN
IN OVARIAN CANCER TREATMENT
A. Du Bois, Wiesbaden, Germany |
| 14:00 |
NEW APPROACHES IN THE TREATMENT OF OVARIAN
CANCER
S. Pecorelli, Brescia, Italy |
| 14:20 |
ONGOING CLINICAL TRIALS
R.F. Ozols, Philadelphia PA, USA |
| 14:40 |
Discussion |
| 15:30 - 17:00 |
Interactive Sessions |
|
| Session 1: |
RARE TUMOUR DATABASE AND WEBSITE
Chairpersons:
N. Reed, Glasgow, UK
J.A. Green, Liverpool, UK |
Hall D |
| 15.30 |
WELCOME & INTRODUCTION
N. Reed, Glasgow, UK
J.A. Green, Liverpool, UK |
|
| 15.35 |
BACKGROUND TO RARE TUMOUR WEBSITE DEVELOPMENT
N. Reed, Glasgow, UK |
|
| 15.50 |
INTEGRATION OF TRANSLATIONAL RESEARCH
INTO PROJECT
J.A. Green, Liverpool, UK |
|
| 16.00 |
SMALL CELL CERVIX PROTOCOL
M.L. Friedlander, Randwick NSW, Australia |
|
| 16.10 |
OVARIAN AND UTERINE SARCOMAS
N. Reed, Glasgow, UK |
|
| 16.20 |
SEX CORD TUMOURS OF OVARY
J.A. Green, Liverpool, UK
|
|
| 16.30 |
LAUNCHING THE WEBSITE & PRACTICAL
ISSUES |
|
| Session 2: |
CONTROVERSY: INCONSISTENCIES BETWEEN SURGICAL
AND CLASSICAL ANATOMY
Chairpersons:
D. Barton, London, UK
H. Fritsch, Innsbruck, Austria |
Hall G |
|
| 15:30 |
FEMALE PELVIC ANATOMY: THE NEED FOR CONSISTENCY
AND A RETURN TO THE BASICS
D.P.J. Barton, London, UK |
| 15:45 |
EMBRYOLOGICAL BASICS FOR SURGICAL ONCOLOGY
ON THE PELVIC FLOOR
H. Fritsch, Innsbruck, Austria |
| 16:00 |
BILATERAL PERINEO-COLPO-RECTO-SACRO-PEXY
WITH POLYPROPYLENE MESH. A NEW SAGGITAL CONCEPT FOR PROLAPSE
SURGERY
H.F. Egger, Nurnberger, Germany |
| 16:15 |
RECTAL SURGERY TRACES THE EMBRYOLOGY OF
THE HINDGUT
R. Heald, Basingstoke, UK |
| 16:30 |
TOTAL MESOMETRIAL RESECTION: APPLIED
EMBRYOLOGY IN GYNECOLOGICAL SURGICAL ONCOLOGY
M. Höckel, Leipzig, Germany |
| 16:45 |
Discussion |
| Session 3: |
CONTROVERSIES IN GYNAECOLOGICAL PATHOLOGY
Chairpersons:
M. Wells, Sheffield, UK
I. Konishi, Matsumoto, Japan |
Hall F |
| 15:30 |
PRECURSOR LESIONS OF HEREDITARY OVARIAN
CANCER - DO THEY EXIST?
P. Shaw, Toronto ON, Canada |
| 15:50 |
IMMUNOHISTOCHEMICAL MARKERS OF VALUE IN
THE DIAGNOSIS OF EPITHELIAL AND STROMAL NEOPLASIA OF THE
FEMALE GENITAL TRACT - HOW RELIABLE ARE THEY?
G. McCluggage, Belfast, UK |
| 16:10 |
ENDOMETRIAL PRECANCERS AND THEIR RELATIONSHIP
TO ENDOMETRIAL CARCINOMA: HISTOLOGICAL AND MOLECULAR CORRELATE
G. Mutter, Boston MA, USA |
| 16:30 |
Discussion |
| Session 4: |
TUMOUR BOARD
Chairpersons:
I. Ackerman, Toronto ON, Canada
N. Teng, Stanford CA, USA
|
Hall H |
| |
Introduction of 5-6 Cases of
CERVIX AND ENDOMETRIAL CANCER
I. Ackerman, Toronto ON, Canada
N. Teng, Stanford CA, USA
|
| Session 5: |
WHAT IS THE BEST SECOND LINE CHEMOTHERAPY
FOR OVARIAN CANCER?
Chairpersons:
J.B. Vermorken, Edegem, Belgium
R.F. Ozols, Philadelphia PA, USA |
Hall I |
| 15:30 |
Single Single agent platinum compounds
in Recurrent Ovarian Cancer
R.F. Ozols, Philadelphia, PA, USA |
| 15:50 |
Single agent non-platinum and non-toxic
compounds
J.B. Vermorken, Edegem, Belgium |
| 16:10 |
The Japanese experience - focus at
clear cell carcinoma
T. Sugiyama, Morioka, Japan |
| 16:30 |
Combination chemotherapy vs single
agent chemotherapy
P. Harper, London, UK |
| 16:50 |
Discussion |
| Session 6: |
DEBATE: 'LYMPH NODE SAMPLING IS A WASTE
OF TIME'
Chairpersons:
I. Vergote, Leuven, Belgium
J. de Hullu, Groningen, The Netherlands |
Hall B |
| 15:30 |
PRO
J. de Hullu, Nijmegen, The Netherlands |
| 16:00 |
AGAINST
I. Vergote, Leuven, Belgium |
| 16:30 |
Discussion |
Session 7:
15:30 - 17:00 |
Selected Poster Presentations
Chairperson:
S. Kehoe, Oxford, UK |
Hall A |
Session 8:
15:30 - 17:00 |
CHEMORADIOTHERAPY IS THE TREATMENT OF
CHOICE FOR
VULVAL CANCER
Chairpersons & Speakers:
G.M. Thomas, Toronto ON, Canada
N.F. Hacker, Randwick NSW, Australia |
Hall C |
| 17:00 - 18:30 |
Frontiers Sessions |
|
| A. |
THE ROLE OF MOLECULAR
GENETICS
Chairpersons:
U. Beller, Jerusalem, Israel
S. Fujii, Kyoto, Japan |
Hall
B |
| 17:00 |
FUNDAMENTALS OF CANCER GENETICS
S. Gayther, London, UK |
| 17:15 |
GENETIC PREDISPOSITION TO OVARIAN CANCER
U. Beller, Jerusalem, Israel |
| 17:30 |
NOVEL ASPECTS OF MOLECULAR GENETICS IN
ENDOMETRIAL CANCERS
S. Kyo, Ishikawa, Japan |
| 17:45 |
MOLECULAR GENETICS IN OVARIAN CANCER PROGRESSION
I. Konishi, Matsumoto, Japan |
| 18:00 |
SENESCENCE INDUCTION FOR GENE THERAPY OF
GYNECOLOGICAL CANCERS BASED ON ITS MOLECULAR MACHINERIES
H. Kato, Fukuoka, Japan |
| 18:15 |
FUTURE PROSPECTS FOR THE ROLE OF MOLECULAR
GENETICS IN GYNAECOLOGICAL CANCER
A. Berchuck, Durham, NC, USA |
| B. |
PROTEOMICS IN CANCER SCREENING AND
DIAGNOSIS
Chairperson:
R. Rees, Nottingham, UK
|
Hall C |
| 17:00 |
INTERROGATION OF THE SERUM PROTEOME USING
MASS SPECTROMETRY
C. Creaser, Nottingham, UK
|
| 17:30 |
DEVELOPING PROTEOMIC TECHNOLOGIES WITH
DIAGNOSTIC / PRDICTIVE POTENTIAL AND ITS APPLICATION TO
A CLINICAL SETTING
S. Mian, Nottingham, UK
|
| 18:00 |
USE OF PROTEOMICS IN OVARIAN CANCER-
A CRITICAL APPRAISAL
T.S. Ganesan, Oxford, UK
|
| C. |
CERVICAL CANCER IN THE DEVELOPING WORLD
Chairpersons:
L.A. Denny, Cape Town, South Africa
|
Hall A |
| 17:00 |
CERVICAL CANCER: SCREENING OPTIONS
Y-T. Kim, Seoul, South Korea |
|
| 17:20 |
CERVICAL CANCER PREVENTION: A PARADIGM
SHIFT
L.A. Denny, Cape Town, South Africa |
|
| 17:40 |
CERVICAL CANCER: THE AFRICAN PERSPECTIVE
R. Anorlu, Lagos, Nigeria |
|
| 18:00 |
CERVICAL CANCER: THE INDIAN PERSPECTIVE
E. Vallikad,, Bangalore, India |
|
| 18.20 |
CERVICAL CANCER AND HIV - WHAT IS THE
CONNECTION?
M. Moodley, Durban, South Africa |
|
<
Top |
|
